Correction: Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study Authors: Mansour Bahardoust, Maryam Zolfaghari Dehkharghani, Pouya Ebrahimi, Maryam Najafirashed, Safa Mousavi, Meisam Haghmoradi, Mohsen Khaleghian, Adnan Tizmaghz Published: 2026 Correction to: BMC Surg (2023) 23:324 https://doi.org/10.1186/s12893-023-02236-8 After publication, and following post-publication peer review by the Journal, several issues were identified in the published article [1]. The authors are therefore making the following corrections to the Patient Characteristics and Discussion sections to address the identified issues: On page 2, paragraph 6, “underwent resection hepatectomy” was added after “the medical profiles of 956 patients with HCC who”, and “patients who underwent lobectomy” was added after “secondary HCC (cases that did not originate from the liver)”. On page 7, paragraph 18, “Comorbidities, R status of resection, adjuvant chemotherapy or portal vein embolization before surgery (to assess for increased residual liver function)” was added after “which made us unable to measure several important factors”. “(Prone to selection bias)” was added after “in addition, due to the retrospective nature”. “Our study was conducted on patients with specific characteristics, so the results should be generalized to other populations with caution” was added after “there were missing cases in a number of variables, which can affect the estimation of the results.” The original article has been corrected. Footnotes Mansour Bahardoust and Maryam Najafirashed are equal to the first authors. References